147 related articles for article (PubMed ID: 34154931)
1. Early detection of cutaneous complications of insulin therapy in type 1 and type 2 diabetes mellitus.
Arora S; Agrawal NK; Shanthaiah DM; Verma A; Singh S; Patne SCU; Kalra S; Singh P; Goyal S
Prim Care Diabetes; 2021 Oct; 15(5):859-864. PubMed ID: 34154931
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of Lipohypertrophy Among People with Type 1 Diabetes in India.
Gupta SS; Gupta KS; Gathe SS; Bamrah P; Gupta SS
Diabetes Technol Ther; 2018 Jul; 20(7):483-491. PubMed ID: 29932731
[TBL] [Abstract][Full Text] [Related]
3. Errors in insulin treatment management and risk of lipohypertrophy.
Pozzuoli GM; Laudato M; Barone M; Crisci F; Pozzuoli B
Acta Diabetol; 2018 Jan; 55(1):67-73. PubMed ID: 29098390
[TBL] [Abstract][Full Text] [Related]
4. Lipohypertrophy in China: Prevalence, Risk Factors, Insulin Consumption, and Clinical Impact.
Ji L; Sun Z; Li Q; Qin G; Wei Z; Liu J; Chandran AB; Hirsch LJ
Diabetes Technol Ther; 2017 Jan; 19(1):61-67. PubMed ID: 28099050
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and risk factors of lipohypertrophy in insulin-injecting patients with diabetes.
Blanco M; Hernández MT; Strauss KW; Amaya M
Diabetes Metab; 2013 Oct; 39(5):445-53. PubMed ID: 23886784
[TBL] [Abstract][Full Text] [Related]
6. Lipohypertrophy in Elderly Insulin-Treated Patients With Type 2 Diabetes.
Gentile S; Guarino G; Della Corte T; Marino G; Fusco A; Corigliano G; Colarusso S; Piscopo M; Improta MR; Corigliano M; Martedi E; Oliva D; Russo V; Simonetti R; Satta E; Romano C; Vaia S; Strollo F; ;
Diabetes Ther; 2021 Jan; 12(1):107-119. PubMed ID: 33219928
[TBL] [Abstract][Full Text] [Related]
7. Insulin-induced lipodystrophy and predisposing factors in children and adolescents with type 1 diabetes mellitus (T1DM) in a tertiary care Egyptian center.
Elsayed S; Soliman AT; De Sanctis V; Fawzy D; Ahmed S; Alaaraj N
Acta Biomed; 2023 Jun; 94(3):e2023078. PubMed ID: 37326270
[TBL] [Abstract][Full Text] [Related]
8. Subclinical lipohypertrophy--Easily ignored complications of insulin therapy.
Luo D; Shi Y; Zhu M; Wang H; Yan D; Yu J; Ji J; Liu X; Fan B; Xu Y; Zhang M; He W; Xu J; Yang T
J Diabetes Complications; 2021 Mar; 35(3):107806. PubMed ID: 33280982
[TBL] [Abstract][Full Text] [Related]
9. Current insight in the localized insulin-derived amyloidosis (LIDA): clinico-pathological characteristics and differential diagnosis.
Ansari AM; Osmani L; Matsangos AE; Li QK
Pathol Res Pract; 2017 Oct; 213(10):1237-1241. PubMed ID: 28935176
[TBL] [Abstract][Full Text] [Related]
10. Worldwide Injection Technique Questionnaire Study: Injecting Complications and the Role of the Professional.
Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
Mayo Clin Proc; 2016 Sep; 91(9):1224-30. PubMed ID: 27594186
[TBL] [Abstract][Full Text] [Related]
11. Insulin-related lipohypertrophy: ultrasound characteristics, risk factors, and impact of glucose fluctuations.
Lin Y; Lin L; Wang W; Hong J; Zeng H
Endocrine; 2022 Mar; 75(3):768-775. PubMed ID: 34648113
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of lipohypertrophy and associated risk factors in insulin-treated patients with type 2 diabetes mellitus.
Al Ajlouni M; Abujbara M; Batieha A; Ajlouni K
Int J Endocrinol Metab; 2015 Apr; 13(2):e20776. PubMed ID: 25926852
[TBL] [Abstract][Full Text] [Related]
13. A meta-analysis and meta-regression on the prevalence of lipohypertrophy in diabetic patients on insulin therapy.
Wang K; Zhang S; Liu C; Chen Y
Therapie; 2021; 76(6):617-628. PubMed ID: 33958198
[TBL] [Abstract][Full Text] [Related]
14. Skin-related complications of insulin therapy: epidemiology and emerging management strategies.
Richardson T; Kerr D
Am J Clin Dermatol; 2003; 4(10):661-7. PubMed ID: 14507228
[TBL] [Abstract][Full Text] [Related]
15. Localized amyloidosis at the site of repeated insulin injection in a patient with type 2 diabetes.
Okamura S; Hayashino Y; Kore-Eda S; Tsujii S
Diabetes Care; 2013 Dec; 36(12):e200. PubMed ID: 24265372
[No Abstract] [Full Text] [Related]
16. Worldwide Injection Technique Questionnaire Study: Population Parameters and Injection Practices.
Frid AH; Hirsch LJ; Menchior AR; Morel DR; Strauss KW
Mayo Clin Proc; 2016 Sep; 91(9):1212-23. PubMed ID: 27594185
[TBL] [Abstract][Full Text] [Related]
17. Diabetes in India's North East Study: Prevailing Insulin Usage and Insulin Injection Practices amongst Type 2 Diabetes Mellitus Patients.
Baruah MP; Bhuyan SB; Kalra S; Tiwaskar MH
J Assoc Physicians India; 2023 Aug; 71(8):11-12. PubMed ID: 37651245
[TBL] [Abstract][Full Text] [Related]
18. Lipohypertrophy Monitoring Study (LIMO): Effect of single use of 4 mm pen needles combined with education on injection site rotation on glycaemic control: Confirmation of an unpleasant truth.
Bochanen N; Decochez K; Heleu E; Cuypers J; Vercammen C; Coremans P; Vanhaverbeke G; Shadid S; Keymeulen B; Bolsens N; De Block C
Diabet Med; 2022 Jan; 39(1):e14672. PubMed ID: 34407260
[TBL] [Abstract][Full Text] [Related]
19. Frequency of Lipohypertrophy and Associated Risk Factors in Young Patients with Type 1 Diabetes: A Cross-Sectional Study.
Al Hayek AA; Robert AA; Braham RB; Al Dawish MA
Diabetes Ther; 2016 Jun; 7(2):259-67. PubMed ID: 26979975
[TBL] [Abstract][Full Text] [Related]
20. Determination of insulin-related lipohypertrophy frequency and risk factors in patients with diabetes.
Korkmaz FN; Gökçay Canpolat A; Güllü S
Endocrinol Diabetes Nutr (Engl Ed); 2022 May; 69(5):354-361. PubMed ID: 35697467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
